Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risperidone-associated priapism in an elderly man

Subramoniam Madhusoodanan, Ronald Brenner, Sanjay Gupta

    The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
    |May 8, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study.

    The lancet. Psychiatry·2021
    Same author

    Sex differences in benzodiazepine misuse among adults with substance use disorders.

    Addictive behaviors·2020
    Same author

    A comparison study of the turnaround time for telepsychiatry versus face-to-face consultations in general hospital nonpsychiatric emergency rooms.

    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2020
    Same author

    Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders.

    Addictive behaviors·2018
    Same author

    Review: Adjunctive pharmacologic approaches for benzodiazepine tapers.

    Drug and alcohol dependence·2018
    Same author

    Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.

    Schizophrenia bulletin·2018